Found 131 articles for: "acne"
Practical Algorithm for Acne Treatment Integrating Skincare and Energy-Based Devices
February 2026 | Volume 25 | Issue 2 | Original Article | 111 | Copyright © February 2026
Background: Energy-based devices (EBDs) are increasingly used to manage acne and its sequelae. While literature supports the use of appropriate skin care for acne, few studies ad...
Read MoreEfficacy and Safety of Clascoterone Cream 1% for Acne Are Independent of Age and Sex
February 2026 | Volume 25 | Issue 2 | Original Article | 119 | Copyright © February 2026
Acne vulgaris is an inflammatory skin condition affecting adolescents and adults of both sexes. Clascoterone cream 1% is indicated for the topical treatment of acne vulgaris in patients ≥12 ye...
Read MoreSkin Improvements in Acne Vulgaris Patients Using Gel-Matrix Moisturizer as a Complement to Topical Treatments
December 2025 | Volume 24 | Issue 12 | Original Article | 1239 | Copyright © December 2025
Background: A novel gel-matrix moisturizer was designed to 1) deliver immediate, long-lasting hydration benefits in a lightweight, non-greasy, noncomedogenic formula that is suit...
Read MoreNourishing the Skin: A Review of Diet's Role in Hidradenitis Suppurativa
November 2025 | Volume 24 | Issue 11 | Original Article | 1103 | Copyright © November 2025
Hidradenitis suppurativa (HS) is a complex skin condition influenced by both genetic and environmental factors. Increasing evidence points to diet as a key contributor to disease severity through...
Read MoreAssessing Cutibacterium Acnes Susceptibility With Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% Gel Use: Six-Month Analysis
November 2025 | Volume 24 | Issue 11 | Original Article | 1106 | Copyright © November 2025
Background: The only approved triple-combination acne treatment – clindamycin phosphate 1.2%/adapalene 0.15%/benzoyl peroxide 3.1% (CAB) gel - demonstrated efficacy/safety ...
Read MoreSafety and Tolerability of Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% Gel for Truncal Acne
August 2025 | Volume 24 | Issue 8 | Original Article | 803 | Copyright © August 2025
Background: Truncal acne is underdiagnosed and undertreated, and it can lead to scarring and postinflammatory hyperpigmentation. However, applying topical treatments to larger sk...
Read MoreNovel 2% Salicylic Acid Cleanser With Polymeric Cleansing Technology Treats Acne Without Compromising Skin Barrier
June 2025 | Volume 24 | Issue 6 | Original Article | 570 | Copyright © June 2025
Background: A novel acne cleanser containing 2% Salicylic acid (SA), Polymeric Cleansing Technology (PCT), and a microgel complex, was evaluated for its efficacy in treating mild...
Read MoreThe Impact on Acne Treatment Regimens if Benzoyl Peroxide-Containing Products are Removed From the Market
June 2025 | Volume 24 | Issue 6 | Features | 586 | Copyright © June 2025
Benzyl peroxide (BPO) has been an important component of many acne treatment regimens. However, an independent testing laboratory, Valisure, filed a Citizen’s Petition with the US Food and ...
Read MoreTreatment of Acne-Induced Macular Hyperpigmentation in Fitzpatrick Skin Types V - VI: A Scoping Review
June 2025 | Volume 24 | Issue 6 | Original Article | 579 | Copyright © June 2025
Acne-induced macular hyperpigmentation (AMH) is a common issue among patients with highly melanated skin, particularly those with Fitzpatrick Skin Types (FST) V - VI, which includes nonwhite pati...
Read MoreExploring the Potential Dermatological Benefits of CGRP Inhibition: A Case Report
June 2025 | Volume 24 | Issue 6 | Case Reports | 636 | Copyright © June 2025
Calcitonin gene-related peptide (CGRP) is a neuropeptide involved in neurogenic inflammation and vasodilation, playing a key role in the pathophysiology of both migraines and inflammatory skin co...
Read MorePost-Isotretinoin Acne Management: A Pilot Survey of the American Acne and Rosacea Society Board of Directors
June 2025 | Volume 24 | Issue 6 | Editorials | e38 | Copyright © June 2025
A Review of the Role of C. Acnes and its Biofilm in Dandruff Pathogenesis
June 2025 | Volume 24 | Issue 6 | Original Article | 566 | Copyright © June 2025
Dandruff is a common skin condition affecting up to half of the world's population. Symptoms include pruritus, inflammation, and flaking. It is thought to be in part due to microbe dysbiosis. Thi...
Read MoreClindamycin Phosphate 1.2%/Adapalene 0.15%/ Benzoyl Peroxide 3.1% for Acne: Results From A 6-Month Open-Label Study
May 2025 | Volume 24 | Issue 5 | Original Article | 516 | Copyright © May 2025
Background: Treatment of acne may require many months of treatment before maximal benefits are observed, and acne sequelae (eg, scarring, dyspigmentation) can persist long a...
Read MoreImprovement in Skin Moisturization and Lack of Barrier Damage Following Treatment With Clascoterone Cream 1%
April 2025 | Volume 24 | Issue 4 | Original Article | 397 | Copyright © April 2025
Background: Topical medications commonly prescribed for the treatment of acne vulgaris may be limited by application-site dryness, which can result in skin barrier damage. This s...
Read MoreAn Algorithm Integrating Acneceuticals into the Management of Acne Vulgaris
April 2025 | Volume 24 | Issue 4 | Original Article | 376 | Copyright © April 2025
Background: Acne vulgaris is a common, chronic cutaneous disorder with numerous efficacious prescription and procedural treatments. Therapy, however, is hampered by medication in...
Read MoreThe Use of Acneceuticals to Improve Acne Care: Introduction of a New Term and Review of the Literature
March 2025 | Volume 24 | Issue 3 | Original Article | 281 | Copyright © March 2025
Background: Acne is a multifactorial inflammatory skin condition that commonly presents to the dermatology clinic. Treatment generally involves the use of pharmaceutical agents a...
Read MoreEfficacy and Consumer Perception of Topical Over-the-Counter Regimens Involving Beta-Hydroxy Acid for Acne Vulgaris
February 2025 | Volume 24 | Issue 2 | Original Article | 162 | Copyright © February 2025
The use of alpha-hydroxy acids (AHAs) and beta-hydroxy acids (BHAs) for acne treatment and their integration into daily skincare routines for better cosmetic outcomes has increasingly become a no...
Read MoreEvaluating Quality and Reliability of Most-Viewed TikTok Videos About Spironolactone
February 2025 | Volume 24 | Issue 2 | Features | e7 | Copyright © February 2025
Early Acne Improvements With Fixed-Combination Topical Therapy: Analysis of the First 4 Weeks of Treatment
January 2025 | Volume 24 | Issue 1 | Original Article | 79 | Copyright © January 2025
Background: Acne treatment can take weeks to deliver noticeable improvements, which may diminish patients' perception of treatment effectiveness and undermine treatment adherence...
Read MoreUtility of Adding Platelet-Rich Plasma to Microneedling vs Microneedling Alone in the Treatment of Acne Scarring
January 2025 | Volume 24 | Issue 1 | Original Article | 41 | Copyright © January 2025
© 2026 Journal of Drugs in Dermatology. All Rights Reserved. JDD, a peer-reviewed, MEDLINE®/PubMed® indexed journal, offers the dermatology community strong content of utmost quality and relevance on drugs, devices, and methods.
